Swedish Cancer Institute Cancer Institute — Seattle, Washington

Swedish Cancer Institute Cancer Institute is a clinical research site located in Seattle, Washington, United States 98104.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

Swedish Cancer Institute Cancer Institute has participated in 1 clinical trials.

Therapeutic areas: Acute Myeloid Leukemia (AML) With, FLT3 Mutation, Internal Tandem Duplication (ITD) or Tyrosine Kinase Domain (TKD).

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Swedish Cancer Institute Cancer Institute?

Swedish Cancer Institute Cancer Institute has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Swedish Cancer Institute Cancer Institute conducted?

Swedish Cancer Institute Cancer Institute has 1 clinical trials on record. Their work covers Acute Myeloid Leukemia (AML) With, FLT3 Mutation, Internal Tandem Duplication (ITD) or Tyrosine Kinase Domain (TKD).

Is Swedish Cancer Institute Cancer Institute accredited by Crixeo Health?

Swedish Cancer Institute Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Swedish Cancer Institute Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.